1. Silibinin-loaded magnetic nanoparticles inhibit hTERT gene expression and proliferation of lung cancer cells.
- Author
-
Amirsaadat S, Pilehvar-Soltanahmadi Y, Zarghami F, Alipour S, Ebrahimnezhad Z, and Zarghami N
- Subjects
- A549 Cells, Cell Proliferation drug effects, Drug Liberation, Humans, Lactic Acid chemistry, Polyethylene Glycols chemistry, Polyglycolic Acid chemistry, Polylactic Acid-Polyglycolic Acid Copolymer, Silybin, Drug Carriers chemistry, Gene Expression Regulation, Neoplastic drug effects, Lung Neoplasms pathology, Magnetite Nanoparticles chemistry, Silymarin chemistry, Silymarin pharmacology, Telomerase genetics
- Abstract
Nanoparticle-based targeted drug delivery has the potential for rendering silibinin specifically at the favorite site using an external magnetic field. Also, it can circumvent the pitfalls of poor solubility. For this purpose, silibinin-loaded magnetic nanoparticles are fabricated, characterized and evaluated cytotoxicity and hTERT gene expression in A549 lung cancer cell line. silibinin-loaded PLGA-PEG-Fe
3 O4 had dose- and time-dependent cytotoxicity than pure silibinin. Additionally, hTERT expression is more efficiently reduced with increasing concentrations of nanosilibinin than pure silibinin. The present study indicates that PLGA-PEG-Fe3 O4 nanoparticles, as an effective targeted carrier, can make a promising horizon in targeted lung cancer therapy.- Published
- 2017
- Full Text
- View/download PDF